News
INGN
26.16
-1.02%
-0.27
Here's Why You Should Hold on to Inogen (INGN) Stock For Now
Investors continue to be optimistic about Inogen (INGN) on its potential in the POC space and a strong product portfolio.
Zacks · 3d ago
Short Volatility Alert: Inogen, Inc.
On Monday, shares of Inogen, Inc. (NASDAQ: INGN) experienced volatile short activity. After the activity, the stock price went down -5.99% to $24.47.  The overall sentiment for INGN has been Bearish.
Benzinga · 06/14 15:20
Inogen Names Agnes Lee as Senior Vice President of Investor Relations and Strategic Planning
GOLETA, Calif., May 18, 2022--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Agnes Lee to the position of Senior Vice President of Inves...
Business Wire · 05/18 20:05
Inogen (INGN) Stock Inches Up 0.5% Post Q1 Earnings Beat
Inogen's (INGN) first-quarter results benefit from higher revenues across the majority of its geographical segments and categories.
Zacks · 05/13 14:12
Stifel Maintains Hold Rating for Inogen: Here's What You Need To Know
Stifel has decided to maintain its Hold rating of Inogen (NASDAQ:INGN) and lower its price target from $40.00 to $30.00. Shares of Inogen are trading down 4.15% over the last 24 hours, at $23.91 per share. A move to $30.00 would account for a 25.5% increas...
Benzinga · 05/09 16:00
--Stifel Adjusts Inogen's Price Target to $30 from $40, Keeps Hold Rating
MT Newswires · 05/09 13:07
--Needham Trims Inogen's Price Target to $45 From $47 on 'Lower Cash Balance,' Reiterates Buy Rating
MT Newswires · 05/06 06:48
Inogen (INGN) Reports Q1 Loss, Tops Revenue Estimates
Inogen (INGN) delivered earnings and revenue surprises of 20.83% and 5.09%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 05/06 00:15
Inogen Q1 Adj. EPS $0.39 Beats $(0.51) Estimate, Sales $80.40M Beat $76.55M Estimate
Inogen (NASDAQ:INGN) reported quarterly earnings of $0.39 per share which beat the analyst consensus estimate of $(0.51) by 176.47 percent. This is a 1400 percent increase over losses of $(0.03) per share from the same
Benzinga · 05/05 21:17
Inogen GAAP EPS of -$0.62 misses by $0.11, revenue of $80.4M beats by $3.84M
Inogen press release (NASDAQ:INGN): Q1 GAAP EPS of -$0.62 misses by $0.11. Revenue of $80.4M (-7.5% Y/Y) beats by $3.84M.
Seekingalpha · 05/05 20:21
-- Earnings Flash (INGN) INOGEN Reports Q1 Revenue $80.4M, vs. Street Est of $76.6M
MT Newswires · 05/05 16:56
-- Earnings Flash (INGN) INOGEN Reports Q1 EPS $-0.39, vs. Street Est of $-0.51
MT Newswires · 05/05 16:55
Is There An Opportunity With Inogen, Inc.'s (NASDAQ:INGN) 41% Undervaluation?
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Inogen, Inc...
Simply Wall St. · 05/03 17:57
Inogen Announces Participation in the 21st Annual Needham Virtual Healthcare Conference
GOLETA, Calif., March 30, 2022--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company’s management will be participating in the 21st Annual Needh...
Business Wire · 03/30 20:05
Here's Why You Should Hold on to Inogen (INGN) Stock Now
Inogen (INGN) continues to benefit from strength in the direct-to-customer business model. However, rising costs remain a woe.
Zacks · 03/29 14:40
We're Interested To See How Inogen (NASDAQ:INGN) Uses Its Cash Hoard To Grow
Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...
Simply Wall St. · 03/23 20:47
BRIEF-Inogen Announces Board Of Director Changes
reuters.com · 03/23 10:03
Inogen Announces Board of Director Changes
GOLETA, California, March 23, 2022--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Glenn Boehnlein, Kevin King, and Mary Katherine Ladon...
Business Wire · 03/23 10:00
Inogen Announces Participation in the KeyBanc Life Sciences & MedTech Investor Forum
GOLETA, Calif., March 10, 2022--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company’s management will be participating in the KeyBanc Life Scie...
Business Wire · 03/10 11:00
Inogen hires new CFO
Inogen (NASDAQ:INGN) has appointed Kristin Caltrider as EVP & Chief Financial Officer, effective March 21, 2022. Ms. Caltrider joins Inogen from Quidel, where she most recently served as Vice President
Seekingalpha · 03/04 11:10
More
Webull provides a variety of real-time INGN stock news. You can receive the latest news about Inogen Inc through multiple platforms. This information may help you make smarter investment decisions.
About INGN
Inogen, Inc. is a medical technology company, which provides respiratory products for use in the homecare setting. The Company primarily develops, manufactures, and markets portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its Inogen One systems concentrate the air around the patient to offer a single source of supplemental oxygen with a single battery and can be plugged into a power outlet as needed. All of its Inogen One systems are equipped with Intelligent Delivery Technology, a form of pulse-dose technology, from which the patient receives a bolus of oxygen upon inhalation. It has also launched Inogen Connect, a wireless connectivity platform for the Inogen One G4 and Inogen One G5 (portable oxygen concentrators) consisting of a front-end mobile application for use by long-term oxygen therapy users and a back-end database portal for use by homecare providers.